Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agomelatine attenuates cisplatin-induced cognitive impairment via modulation of BDNF/TrkB signaling in rat hippocampus
Sinan Saral, Atilla Topçu, Mehmet Alkanat, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 130, pp. 102269-102269
Closed Access | Times Cited: 9

Showing 9 citing articles:

Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics
Shaoyi Fang, Zhibin Wu, Yali Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?
Jelena Katanić, Dragica Selaković, Gvozden Rosić
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14574-14574
Open Access | Times Cited: 17
Functional Remediation Improves Serum BDNF and TrkB Levels in Euthymic Patients with Bipolar Disorder: A Randomized Trial Study
Li Ru, Jiaxin Li, Shiyi Ji, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 115-128
Open Access
Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
Zarah R. Haniff, Mariia Bocharova, Tim Mantingh, et al.
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108641-108641
Open Access | Times Cited: 4
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity
Naomi Lomeli, Diana C. Pearre, Maureen T. Cruz, et al.
Experimental Neurology (2024) Vol. 375, pp. 114717-114717
Open Access | Times Cited: 3
Agomelatine on cisplatin-induced nephrotoxicity via oxidative stress and apoptosis
Eyüp Dil, Atilla Topçu, Tolga Mercantepe, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 10, pp. 2753-2764
Closed Access | Times Cited: 5
Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder
Dasiel O. Borroto‐Escuela, Pedro Jesús Serrano Castro, Jose Andrés Sánchez‐Pérez, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 4, pp. 295-308
Open Access | Times Cited: 1
Pharmacology, medical uses, and clinical translational challenges of Saikosaponin A: a review
Xiaohong Sun, Yoke Chin Chai, Xue Bai, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40427-e40427
Open Access | Times Cited: 1
Dexmedetomidine Improves Learning Functions in Male Rats Modeling Cognitive Impairment by Modulating the BDNF/TrkB/CREB Signaling Pathway
Sinan Saral, Tolga Mercantepe, Atilla Topçu, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1672-1672
Open Access
Page 1

Scroll to top